Myocardial fibrosis predicts adverse outcome after MitraClip implantation.

Juliëtte F VeluAlexander HirschS M BoekholdtKarel T KochM Marije VisR Nils PlankenJan J PiekJan BaanBerto J Bouma

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)

Our hypothesis-generating study showed that the presence of myocardial fibrosis predicts adverse outcome in patients undergoing MitraClip implantation. After confirmation with larger sample size, identification of myocardial fibrosis might contribute to assess prognosis and to clinical decision making.

Keyphrases

left ventricular
mitral valve
patients undergoing
decision making
liver fibrosis
adverse drug
emergency department
atrial fibrillation
drug induced